IGF1 and sensorineural hearing loss disorder: IGF‐1 is regarded as a new, promising therapeutic agent for treating sensorineural hearing loss and has undergone clinical trials in patients with idiopathic sudden sensorineural hearing loss that is refractory to systemic steroid therapy.32, 33